Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies

Authors Chenel V, Boissy P, Poirier MS, Cloarec JP, Patenaude J

Received 6 December 2014

Accepted for publication 22 January 2015

Published 16 March 2015 Volume 2015:10(1) Pages 2125—2139

DOI https://doi.org/10.2147/IJN.S78799

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Editor who approved publication: Dr Thomas J Webster

Vanessa Chenel,1–4 Patrick Boissy,1–3 Marie-Sol Poirier,1–3 Jean-Pierre Cloarec,3,4 Johane Patenaude1–3

1Interdisciplinary Institute for Technological Innovation (3IT), 2Department of Surgery, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada; 3Laboratoire Nanotechnologies et Nanosystèmes (LN2), Centre National de la Recherche Scientifique (CNRS), Université de Sherbrooke, Canada; 4Université de Lyon, Institut des Nanotechnologies de Lyon (INL), site École Centrale de Lyon, France


Background: Despite marked optimism in the field of nanomedicine about the use of drug-delivery nanocarriers, uncertainties exist concerning nanocarriers’ possible unintended impacts and effects. These uncertainties could affect user acceptance and acceptability. “Acceptance” refers to the intention to put a technology or a device to a specified use. “Acceptability” refers to a value judgment that accounts for acceptance. The objectives of this study were to characterize impact perception, acceptance, and acceptability in relation to drug-delivery nanocarriers in different contexts of use, and to explore relationships among these concepts.
Methods: A sample of European and Canadian researchers and graduate research trainees active in the field of new technologies was recruited by targeted email invitation for participation in a web-based questionnaire study. The questionnaire presented scenarios for two contexts of use (lung cancer, seasonal flu) of drug-delivery nanocarriers with two compositions (carbon, synthetic DNA). Respondents’ impact perception, acceptance, and acceptability judgment in relation to each kind of nanocarrier in each context of use were measured with Likert scale questions and scored using categorical values.
Results: Two hundred and fourteen researchers and graduate research trainees completed the questionnaire. The results showed that nanocarrier composition influenced impact perception: as compared with the carbon nanocarrier impact perception, the positive impacts of the synthetic DNA nanocarrier were perceived as more significant and more likely to occur than its negative impacts. Composition did not influence acceptance or acceptability. Context of use significantly influenced acceptance and acceptability of both kinds of nanocarriers: researchers were more likely to accept the use of nanocarriers to treat lung cancer than the seasonal flu. The results also showed a significant relationship between acceptance and the perceived usefulness of the treatments.
Conclusion: Nanocarrier composition does not appear to influence acceptance or acceptability. On the other hand, the nanocarriers’ perceived usefulness and context of use are both major factors in accounting for acceptance and acceptability.

Keywords: acceptance, impact perception, nanomedicine, researchers’ perceptions, ELSI, E3LS

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Molecular targets in arthritis and recent trends in nanotherapy

Roy K, Kanwar RK, Kanwar JR

International Journal of Nanomedicine 2015, 10:5407-5420

Published Date: 26 August 2015

Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers

Farooqi AA, Tang JY, Li RN, Ismail M, Chang YT, Shu CW, Yuan SSF, Liu JR, Mansoor Q, Huang CJ, Chang HW

International Journal of Nanomedicine 2015, 10:3183-3191

Published Date: 24 April 2015

Non-chemotoxic induction of cancer cell death using magnetic nanowires

Contreras MF, Sougrat R, Zaher A, Ravasi T, Kosel J

International Journal of Nanomedicine 2015, 10:2141-2153

Published Date: 17 March 2015

Electrospun gelatin/polycaprolactone nanofibrous membranes combined with a coculture of bone marrow stromal cells and chondrocytes for cartilage engineering

He X, Feng B, Huang C, Wang H, Ge Y, Hu R, Yin M, Xu Z, Wang W, Fu W, Zheng J

International Journal of Nanomedicine 2015, 10:2089-2099

Published Date: 17 March 2015

Hydroxypropylcellulose as a novel green reservoir for the synthesis, stabilization, and storage of silver nanoparticles

Hussain MA, Shah A, Jantan I, Shah MR, Tahir MN, Ahmad R, Bukhari SN

International Journal of Nanomedicine 2015, 10:2079-2088

Published Date: 16 March 2015

Glioma-targeting micelles for optical/magnetic resonance dual-mode imaging

Zhou Q, Mu K, Jiang L, Xie H, Liu W, Li Z, Qi H, Liang S, Xu H, Zhu Y, Zhu W, Yang X

International Journal of Nanomedicine 2015, 10:1805-1818

Published Date: 5 March 2015

Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification

Zeng WJ, Peng CW, Yuan JP, Cui R, Li Y

International Journal of Nanomedicine 2015, 10:1759-1768

Published Date: 5 March 2015

Public attitudes about lung cancer: stigma, support, and predictors of support

Weiss J, Stephenson BJ, Edwards LJ, Rigney M, Copeland A

Journal of Multidisciplinary Healthcare 2014, 7:293-300

Published Date: 16 July 2014

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010